Form D — Osteal Therapeutics, Inc.
0001231919-25-000432 · filed Nov 5, 2025
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $26,702,156
- Total sold
- $15,602,151
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Osteal Therapeutics, Inc.
- CIK
- 1735936
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4835 LYNDON B. JOHNSON FWY STE 635
DALLAS, TX 75244 - Phone
- (469) 809-2630
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Thompson · Executive OfficerDALLAS, TX Find on LinkedIn ↗
-
Erik Oros · DirectorDALLAS, TX Find on LinkedIn ↗
-
Sonal Patel · DirectorDALLAS, TX Find on LinkedIn ↗
-
Martin Sands · DirectorDALLAS, TX Find on LinkedIn ↗
-
Rushu Luo · DirectorDALLAS, TX Find on LinkedIn ↗
-
Judson Cooper · DirectorDALLAS, TX Find on LinkedIn ↗
-
Biren Mehta · DirectorDALLAS, TX Find on LinkedIn ↗
-
David Cash · DirectorDALLAS, TX Find on LinkedIn ↗
-
Brian de Beaubien · Executive OfficerDALLAS, TX Find on LinkedIn ↗
-
Douglas Kohrs · DirectorDALLAS, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗